Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants

Journal of Infectious Diseases

Volumn 182, Issue 4, 2000, Pages 1260-1263

  Choo, Sharon ^a   Zhang, Qibo ^a   Seymour, Lynn ^a   Akhtar, Samia ^a   Finn, Adam ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SERODIAGNOSIS; STREPTOCOCCUS INFECTION;

ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SALIVA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; VACCINES, CONJUGATE;

EID: 0033795880     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315834     Document Type: Article

References (17)

1. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants
2. Safety and immunogenicity of heptavalent pneumococcal CRM(197), conjugate vaccine in infants and toddlers
3. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
4. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
5. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine
6. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines
7. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
8. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents
9. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
10. Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Hib conjugate vaccine in infants
11. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid
12. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens
13. Streptococcuspneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunological memory
14. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid
15. Antibody response to pneumococcal capsular polysaccharide vaccine in African children
16. Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea
17. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats